NCT02813200View on ClinicalTrials.gov

Description of the Ability to Learn How to Handle Inhaler Devices in COPD

PHASE4CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

January 10, 2017

Primary Completion Date

February 28, 2019

Study Completion Date

March 8, 2019

Conditions
Chronic Obstructive Pulmonary Disease (COPD)
Interventions
DRUG

Seretide® Diskus® 500/550 μg

Every day during 7 days

DRUG

Ultibro® Breezhaler® 110/50 μg

Every day during 7 days

DRUG

Spiriva® Respimat® 2,5 μg

Every day during 7 days

Trial Locations (1)

33604

CIC-P - Centre François Magendie - G3 - Hôpital Haut-Lévêque, Bordeaux

All Listed Sponsors
lead

University Hospital, Bordeaux

OTHER

NCT02813200 - Description of the Ability to Learn How to Handle Inhaler Devices in COPD | Biotech Hunter | Biotech Hunter